 Connection
Spyridoula Maraka to Antithyroid Agents
This is a "connection" page, showing publications Spyridoula Maraka has written about Antithyroid Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.598 |
|
|
|
-
El Kawkgi O, Toro-Tobon D, Toloza FJK, Vallejo S, Jacome CS, Ayala IN, Vallejo BA, Wenczenovicz C, Tzeng O, Spencer HJ, Thostenson JD, Li D, Kohlenberg J, Lincango E, Mohan S, Castellanos-Diaz J, Maraka S, Ospina NS, Brito JP. A Predictive Model for Graves' Disease Recurrence After Antithyroid Drug Therapy: A Retrospective Multicenter Cohort Study. Endocr Pract. 2025 Apr; 31(4):455-464.
Score: 0.241
-
Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, I?iguez-Ariza NM, Montori VM, Stan MN. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study. Thyroid. 2020 03; 30(3):357-364.
Score: 0.173
-
Brito JP, Schilz S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, Montori VM. Antithyroid Drugs-The Most Common Treatment for Graves' Disease in the United States: A Nationwide Population-Based Study. Thyroid. 2016 08; 26(8):1144-5.
Score: 0.134
-
Hidalgo J, Vallejo S, El Kawkgi OM, Ospina NMS, Maraka S, Brito JP. Individualized Graves' disease remission rates conversations: a videographic analysis of medical encounters. Endocrine. 2022 04; 76(1):237-239.
Score: 0.049
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|